As of 2025-05-16, the Intrinsic Value of Windtree Therapeutics Inc (WINT) is -13.30 USD. This WINT valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.83 USD, the upside of Windtree Therapeutics Inc is -1,702.25%.
Based on its market price of 0.83 USD and our intrinsic valuation, Windtree Therapeutics Inc (WINT) is overvalued by 1,702.25%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -13.30 - -13.30 | -13.30 | -1,702.25% |
| P/E | (21.81) - (37.24) | (28.59) | -3544.8% |
| DDM - Stable | (7.61) - (22.08) | (14.84) | -1888.1% |
| DDM - Multi | (12.10) - (30.22) | (17.56) | -2215.9% |
| Market Cap (mil) | 3.03 |
| Beta | 1.82 |
| Outstanding shares (mil) | 3.65 |
| Enterprise Value (mil) | 1.49 |
| Market risk premium | 4.60% |
| Cost of Equity | 21.66% |
| Cost of Debt | 5.00% |
| WACC | 6.72% |